Skip to content
2000
Volume 33, Issue 6
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Introduction

Chronic Renal Failure (CRF) is a progressive disease that severely affects patients' quality of life, but its current treatment options remain limited. This study explores the potential mechanism of Eriobotryae Folium (EF) in treating CRF by targeting ferroptosis.

Methods

Active compounds and targets of EF were identified through multiple databases (TCMSP, SwissTargetPrediction, UniProt, GeneCards, DrugBank). Using Cytoscape and STRING, both a compound-target network and a PPI network were generated. GO and KEGG analyses were conducted to explore relevant biological functions and pathways. The binding affinity and stability between critical compounds and target proteins were investigated through molecular docking and Molecular Dynamics (MD) simulations.

Results

Eighteen active compounds and 366 targets of EF were identified, along with 1,267 CRF-related and 1,673 ferroptosis-related targets, with 40 overlapping genes. PPI analysis highlighted AKT1, EGFR, HIF1A, SRC, and ESR1 as key targets. The KEGG analysis indicated MAPK and HIF-1 pathways as major regulatory pathways. Molecular docking suggested quercetin, ellagic acid, and oleanolic acid as potential active compounds, with EGFR and SRC as promising targets. MD simulations confirmed strong and stable binding, especially for EGFR-ellagic acid (-21.38 kcal/mol) and EGFR-oleanolic acid (-24.02 kcal/mol).

Discussion

This study suggests that EF treats CRF by targeting ferroptosis-related pathways and key proteins, such as EGFR and AKT1. MAPK and HIF-1 signaling pathways further substantiate its significant role in disease regulation.

Conclusion

EF may regulate ferroptosis through multiple targets and pathways, offering potential therapeutic benefits for CRF. The findings offer foundational insights for subsequent research and therapeutic development.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673409766250729110405
2025-09-29
2026-02-24

  • From This Site

    /content/journals/cmc/10.2174/0109298673409766250729110405
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. FlytheJ.E. WatnickS. Dialysis for chronic kidney failure.JAMA2024332181559157310.1001/jama.2024.1633839356511
     [Google Scholar]
  2. TerzoC. GembilloG. CernaroV. LonghitanoE. CalabreseV. CasuscelliC. PeritoreL. SantoroD. Investigational new drugs for the treatment of chronic renal failure: An overview of the literature.Expert Opin. Investig. Drugs202433431933410.1080/13543784.2024.232662438429874
     [Google Scholar]
  3. LongD. MaoC. HuangY. XuY. ZhuY. Ferroptosis in ulcerative colitis: Potential mechanisms and promising therapeutic targets.Biomed. Pharmacother.202417511672210.1016/j.biopha.2024.11672238729051
     [Google Scholar]
  4. ZhouQ. MengY. LiD. YaoL. LeJ. LiuY. SunY. ZengF. ChenX. DengG. Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.Signal Transduct. Target. Ther.2024915510.1038/s41392‑024‑01769‑538453898
     [Google Scholar]
  5. LiuG. XieX. LiaoW. ChenS. ZhongR. QinJ. HeP. XieJ. Ferroptosis in cardiovascular disease.Biomed. Pharmacother.202417011605710.1016/j.biopha.2023.11605738159373
     [Google Scholar]
  6. WenzelS.E. TyurinaY.Y. ZhaoJ. St CroixC.M. DarH.H. MaoG. TyurinV.A. AnthonymuthuT.S. KapralovA.A. AmoscatoA.A. Mikulska-RuminskaK. ShrivastavaI.H. KennyE.M. YangQ. RosenbaumJ.C. SparveroL.J. EmletD.R. WenX. MinamiY. QuF. WatkinsS.C. HolmanT.R. VanDemarkA.P. KellumJ.A. BaharI. BayırH. KaganV.E. PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals.Cell20171713628641.e2610.1016/j.cell.2017.09.04429053969
     [Google Scholar]
  7. JiayiH. ZiyuanT. TianhuaX. MingyuZ. YutongM. JingyuW. HongliZ. LiS. Copper homeostasis in chronic kidney disease and its crosstalk with ferroptosis.Pharmacol. Res.202420210713910.1016/j.phrs.2024.10713938484857
     [Google Scholar]
  8. PawłowskaA.M. ŻurekN. KapustaI. De LeoM. BracaA. Antioxidant and antiproliferative activities of phenolic extracts of Eriobotrya japonica (Thunb.) Lindl. fruits and leaves.Plants20231218322110.3390/plants1218322137765385
     [Google Scholar]
  9. ChenZ. ZhangL. ChenG. Microwave-assisted extraction followed by capillary electrophoresis-amperometric detection for the determination of antioxidant constituents in Folium Eriobotryae.J. Chromatogr. A.200811931-217818110.1016/j.chroma.2008.04.03218462740
     [Google Scholar]
  10. ZhangJ. LiY. ChenS.S. ZhangL. WangJ. YangY. ZhangS. PanY. WangY. YangL. Systems pharmacology dissection of the anti-inflammatory mechanism for the medicinal herb Folium eriobotryae.Int. J. Mol. Sci.20151622913294110.3390/ijms1602291325636035
     [Google Scholar]
  11. JieX.L. LuoZ.R. YuJ. TongZ.R. LiQ.Q. WuJ.H. TaoY. FengP.S. LanJ.P. WangP. Pi-Pa-Run-Fei-Tang alleviates lung injury by modulating IL-6/JAK2/STAT3/IL-17 and PI3K/AKT/NF-κB signaling pathway and balancing Th17 and Treg in murine model of OVA-induced asthma.J. Ethnopharmacol.202331711671910.1016/j.jep.2023.11671937268260
     [Google Scholar]
  12. SarkakiA. HoseinynejadK. Khombi ShooshtariM. RashnoM. Synaptic plasticity and cognitive impairment consequences to acute kidney injury: Protective role of ellagic acid.Iran. J. Basic Med. Sci.202225562162810.22038/IJBMS.2022.62015.1372935911650
     [Google Scholar]
  13. TuH. MaD. LuoY. TangS. LiY. ChenG. WangL. HouZ. ShenC. LuH. ZhuangX. ZhangL. Quercetin alleviates chronic renal failure by targeting the PI3k/Akt pathway.Bioengineered.20211216538655810.1080/21655979.2021.197387734528858
     [Google Scholar]
  14. KasunoK. YodoiJ. IwanoM. Urinary thioredoxin as a biomarker of renal redox dysregulation and a companion diagnostic to identify responders to redox-modulating therapeutics.Antioxid. Redox Signal.20223613-151051106510.1089/ars.2021.019434541903
     [Google Scholar]
  15. FuH. LiW. LiuJ. TangQ. WengZ. ZhuL. DingB. Ellagic acid inhibits dihydrotestosterone-induced ferroptosis and promotes hair regeneration by activating the wnt/β-catenin signaling pathway.J. Ethnopharmacol.202433011822710.1016/j.jep.2024.11822738685364
     [Google Scholar]
  16. XieR. ZhaoW. LoweS. BentleyR. HuG. MeiH. JiangX. SunC. WuY. Yueying liu Quercetin alleviates kainic acid-induced seizure by inhibiting the Nrf2-mediated ferroptosis pathway.Free Radic. Biol. Med.202219121222610.1016/j.freeradbiomed.2022.09.00136087883
     [Google Scholar]
  17. ZhangJ. XuH.Y. WuY.J. ZhangX. ZhangL.Q. LiY.M. Neutrophil elastase inhibitory effects of pentacyclic triterpenoids from Eriobotrya japonica (loquat leaves).J. Ethnopharmacol.201924211171310.1016/j.jep.2019.01.03730703491
     [Google Scholar]
  18. ElshafeiS.O. MahmoudN.A. AlmoftiY.A. Immunoinformatics, molecular docking and dynamics simulation approaches unveil a multi epitope-based potent peptide vaccine candidate against avian leukosis virus.Sci. Rep.2024141287010.1038/s41598‑024‑53048‑638311642
     [Google Scholar]
  19. NadaH. LeeK. GotinaL. PaeA.N. ElkamhawyA. Identification of novel discoidin domain receptor 1 (DDR1) inhibitors using E-pharmacophore modeling, structure-based virtual screening, molecular dynamics simulation and MM-GBSA approaches.Comput. Biol. Med.202214210521710.1016/j.compbiomed.2022.10521735032738
     [Google Scholar]
  20. GaoW.C. WangX.P. HeL.S. Quality evaluation of crude drug and different processed products of Eriobotryae Folium.China Pharmacy202219620210.6039/j.issn.1001‑0408.2022.02.12
     [Google Scholar]
  21. IoutsiA. SarnitskayaA. SumtsovM. Simultaneous determination of general active ingredients in topical formulations by gas chromatography with flame ionization detection (GC-FID).J. Chromatogr. Sci.2023627bmad08610.1093/chromsci/bmad08637965747
     [Google Scholar]
  22. GreytakA.B. AbiodunS.L. BurrellJ.M. CookE.N. JayaweeraN.P. IslamM.M. ShakerA.E. Thermodynamics of nanocrystal–ligand binding through isothermal titration calorimetry.Chem. Commun.20225894130371305810.1039/D2CC05012A36353927
     [Google Scholar]
  23. KimS. ChenJ. ChengT. GindulyteA. HeJ. HeS. LiQ. ShoemakerB.A. ThiessenP.A. YuB. ZaslavskyL. ZhangJ. BoltonE.E. PubChem 2023 update.Nucleic Acids Res.202351D1D1373D138010.1093/nar/gkac95636305812
     [Google Scholar]
  24. BermanH.M. WestbrookJ. FengZ. GillilandG. BhatT.N. WeissigH. ShindyalovI.N. BourneP.E. The protein data bank.Nucleic Acids Res.200028123524210.1093/nar/28.1.23510592235
     [Google Scholar]
  25. Al-FarrajE.S. YounisA.M. El-ReashG.M.I.A. Synthesis, characterization, biological potency, and molecular docking of Co 2+ , Ni 2+ and Cu 2+ complexes of a benzoyl isothiocyanate based ligand.Sci. Rep.20241411003210.1038/s41598‑024‑58108‑538693156
     [Google Scholar]
  26. NiB. WangH. KhalafH.K.S. BlayV. HoustonD.R. AutoDock-SS: AutoDock for multiconformational ligand-based virtual screening.J. Chem. Inf. Model.20246493779378910.1021/acs.jcim.4c0013638624083
     [Google Scholar]
  27. TangS. DingJ. ZhuX. WangZ. ZhaoH. WuJ. Vina-GPU 2.1: Towards further optimizing docking speed and precision of AutoDock Vina and its derivatives.IEEE/ACM Trans. Comput. Biol. Bioinformatics20242162382239310.1109/TCBB.2024.346712739320991
     [Google Scholar]
  28. OancaG. van der EntF. ÅqvistJ. Efficient empirical valence bond simulations with gromacs.J. Chem. Theory Comput.202319176037604510.1021/acs.jctc.3c0071437623818
     [Google Scholar]
  29. BhadraP. SiuS.W.I. Refined empirical force field to model protein–self-assembled monolayer interactions based on AMBER14 and GAFF.Langmuir201935299622963310.1021/acs.langmuir.9b0136731246036
     [Google Scholar]
  30. LuedemannM. StadlerD. ChengC.C. ProtzerU. KnolleP.A. DonakondaS. Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing.Comput. Struct. Biotechnol. J.20222079981110.1016/j.csbj.2022.01.02435126884
     [Google Scholar]
  31. SainiR.S. BinduhayyimR.I.H. GurumurthyV. AlshadidiA.A.F. AldosariL.I.N. OkshahA. KuruniyanM.S. DermawanD. AvetisyanA. MosaddadS.A. HeboyanA. Dental biomaterials redefined: Molecular docking and dynamics-driven dental resin composite optimization.BMC Oral Health202424155710.1186/s12903‑024‑04343‑138735940
     [Google Scholar]
  32. BettadjF.Z.Y. BenchoukW. GuendouziA. Computational exploration of novel ketoprofen derivatives: Molecular dynamics simulations and MM-PBSA calculations for COX-2 inhibition as promising anti-inflammatory drugs.Comput. Biol. Med.202418310920310.1016/j.compbiomed.2024.10920339395347
     [Google Scholar]
  33. ZhangC. LiX. GaoD. ZhuH. WangS. TanB. YangA. Network pharmacology and experimental validation of the anti-inflammatory effect of Tingli Dazao Xiefei decoction in acute lung injury treatment.J Inflamm Res2023166195620910.2147/JIR.S43384038145012
     [Google Scholar]
  34. HollingsworthS.A. DrorR.O. Molecular dynamics simulation for all.Neuron20189961129114310.1016/j.neuron.2018.08.01130236283
     [Google Scholar]
  35. CoutsiasE.A. WesterM.J. RMSD and Symmetry.J. Comput. Chem.201940151496150810.1002/jcc.2580230828834
     [Google Scholar]
  36. ZhaoY. ZhangJ. ZhangH. GuS. DengY. TuY. HouT. KangY. Sigmoid accelerated molecular dynamics: An efficient enhanced sampling method for biosystems.J. Phys. Chem. Lett.20231441103111210.1021/acs.jpclett.2c0368836700836
     [Google Scholar]
  37. MaX. Neek-AmalM. SunC. Advances in two-dimensional ion-selective membranes: Bridging nanoscale insights to industrial-scale salinity gradient energy harvesting.ACS Nano20241820126101263810.1021/acsnano.3c1164638733357
     [Google Scholar]
  38. Al KhzemA.H. ShoaibT.H. MukhtarR.M. AlturkiM.S. GomaaM.S. HusseinD. TawfeeqN. BanoM. SarafrozM. AlzahraniR. AlghamdiH. Rants’oT.A. Repurposing FDA-approved agents to develop a prototype Helicobacter pylori shikimate kinase (HPSK) inhibitor: A computational approach using virtual screening, MM-GBSA calculations, MD simulations, and DFT analysis.Pharmaceuticals202518217410.3390/ph1802017440005988
     [Google Scholar]
  39. WangY. YangJ. ZhangY. ZhouJ. Focus on mitochondrial respiratory chain: Potential therapeutic target for chronic renal failure.Int. J. Mol. Sci.202425294910.3390/ijms2502094938256023
     [Google Scholar]
  40. BayırH. DixonS.J. TyurinaY.Y. KellumJ.A. KaganV.E. Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney.Nat. Rev. Nephrol.202319531533610.1038/s41581‑023‑00689‑x36922653
     [Google Scholar]
  41. JinL. YuB. WangH. ShiL. YangJ. WuL. GaoC. PanH. HanF. LinW. LaiE.Y. WangY.F. YangY. STING promotes ferroptosis through NCOA4-dependent ferritinophagy in acute kidney injury.Free Radic. Biol. Med.202320834836010.1016/j.freeradbiomed.2023.08.02537634745
     [Google Scholar]
  42. ChenW. WangB. LiangS. ZhengL. FangH. XuS. ZhangT. WangM. HeX. FengW. Fullerenols as efficient ferroptosis inhibitor by targeting lipid peroxidation for preventing drug-induced acute kidney injury.J Colloid Interface Sci2025680Pt A26127310.1016/j.jcis.2024.10.19839509775
     [Google Scholar]
  43. GuoR. DuanJ. PanS. ChengF. QiaoY. FengQ. LiuD. LiuZ. The road from AKI to CKD: Molecular mechanisms and therapeutic targets of ferroptosis.Cell Death Dis.202314742610.1038/s41419‑023‑05969‑937443140
     [Google Scholar]
  44. LiS. HanQ. LiuC. WangY. LiuF. PanS. ZuoL. GaoD. ChenK. FengQ. LiuZ. LiuD. Role of ferroptosis in chronic kidney disease.Cell Commun. Signal.202422111310.1186/s12964‑023‑01422‑838347570
     [Google Scholar]
  45. ZhuY. YuC. ZhuangS. Protein arginine methyltransferase 1 mediates renal fibroblast activation and fibrogenesis through activation of Smad3 signaling.Am. J. Physiol. Renal Physiol.20203182F375F38710.1152/ajprenal.00487.201931813251
     [Google Scholar]
  46. HuangX. HouR. PanW. WuD. ZhaoW. LiQ. A functional polysaccharide from Eriobotrya japonica relieves myocardial ischemia injury via anti-oxidative and anti-inflammatory effects.Food Funct.202213111312010.1039/D1FO03208A34878451
     [Google Scholar]
  47. KhouyaT. RamchounM. ElbounyH. HmidaniA. BouhlaliE.T. AlemC. Loquat ( Eriobotrya japonica (Thunb) Lindl.): Evaluation of nutritional value, polyphenol composition, antidiabetic effect, and toxicity of leaf aqueous extract.J. Ethnopharmacol.202229611547310.1016/j.jep.2022.11547335718052
     [Google Scholar]
  48. JianT. ZhouL. ChenY. TianY. WuR. TongB. NiuG. GaiY. LiW. ChenJ. Total sesquiterpenoids of loquat leaves alleviated high-fat diet-induced obesity by targeting fecal metabolic profiling and gut microbiota composition.J. Agric. Food Chem.20227041132791328810.1021/acs.jafc.2c0490036198678
     [Google Scholar]
  49. HajiluianG. KaregarS.J. ShidfarF. AryaeianN. SalehiM. LotfiT. FarhangniaP. HeshmatiJ. DelbandiA.A. The effects of Ellagic acid supplementation on neurotrophic, inflammation, and oxidative stress factors, and indoleamine 2, 3-dioxygenase gene expression in multiple sclerosis patients with mild to moderate depressive symptoms: A randomized, triple-blind, placebo-controlled trial.Phytomedicine202312115509410.1016/j.phymed.2023.15509437806153
     [Google Scholar]
  50. KontoghiorghesG.J. The importance and essentiality of natural and synthetic chelators in medicine: Increased prospects for the effective treatment of iron overload and iron deficiency.Int. J. Mol. Sci.2024259465410.3390/ijms2509465438731873
     [Google Scholar]
  51. YangX. ChuF. JiaoZ. YuH. YangW. LiY. LuC. MaH. WangS. LiuZ. QinS. SunH. Ellagic acid ameliorates arsenic-induced neuronal ferroptosis and cognitive impairment via Nrf2/GPX4 signaling pathway.Ecotoxicol. Environ. Saf.202428311683310.1016/j.ecoenv.2024.11683339128446
     [Google Scholar]
  52. ChenS. ZhouM. YingX. ZhouC. Ellagic acid protects rats from chronic renal failure via MiR-182/FOXO3a axis.Mol. Immunol.202113815016010.1016/j.molimm.2021.08.00734428620
     [Google Scholar]
  53. FengQ. YangY. QiaoY. ZhengY. YuX. LiuF. WangH. ZhengB. PanS. RenK. LiuD. LiuZ. Quercetin ameliorates diabetic kidney injury by inhibiting ferroptosis via activating Nrf2/HO-1 signaling pathway.Am. J. Chin. Med.2023514997101810.1142/S0192415X2350046537046368
     [Google Scholar]
  54. WangY. QuanF. CaoQ. LinY. YueC. BiR. CuiX. YangH. YangY. BirnbaumerL. LiX. GaoX. Quercetin alleviates acute kidney injury by inhibiting ferroptosis.J. Adv. Res.20212823124310.1016/j.jare.2020.07.00733364059
     [Google Scholar]
  55. ChenJ. ZhangH. YangY. ChenB. Quercetin regulates vascular endothelium function in chronic renal failure via modulation of Eph/Cav-1 signaling.Drug Dev. Res.20228351167117510.1002/ddr.2194035470469
     [Google Scholar]
  56. LiuY. LiT. BaiJ. LiuW. WangZ. FengC. PuL. WangX. LiuH. Isoquercitrin attenuates the osteoclast-mediated bone loss in rheumatoid arthritis via the Nrf2/ROS/NF-κB pathway.Biochim. Biophys. Acta Mol. Basis Dis.20241870216697710.1016/j.bbadis.2023.16697738065271
     [Google Scholar]
  57. RuY. LuoY. LiuD. HuangQ. ZhouX. LinghuM. LuoX. LvZ. WuY. ZhangH. HuangY. Isorhamnetin alleviates ferroptosis-mediated colitis by activating the NRF2/HO-1 pathway and chelating iron.Int. Immunopharmacol.202413511231810.1016/j.intimp.2024.11231838795598
     [Google Scholar]
  58. KongX. ZhaoL. HuangH. KangQ. LuJ. ZhuJ. Isorhamnetin ameliorates hyperuricemia by regulating uric acid metabolism and alleviates renal inflammation through the PI3K/AKT/NF-κB signaling pathway.Food Funct.20251672840285610.1039/D4FO04867A40111208
     [Google Scholar]
  59. CastellanoJ.M. Ramos-RomeroS. PeronaJ.S. Oleanolic acid: Extraction, characterization and biological activity.Nutrients202214362310.3390/nu1403062335276982
     [Google Scholar]
  60. XiaX. LiuH. LvH. ZhangJ. ZhouJ. ZhaoZ. Preparation, characterization, and in vitro/vivo studies of oleanolic acid-loaded lactoferrin nanoparticles.Drug Des. Devel. Ther.2017111417142710.2147/DDDT.S13399728533680
     [Google Scholar]
  61. SunH. PengG. ChenK. XiongZ. ZhuangY. LiuM. NingX. YangH. DengJ. Identification of EGFR as an essential regulator in chondrocytes ferroptosis of osteoarthritis using bioinformatics, in vivo , and in vitro study.Heliyon202399e1997510.1016/j.heliyon.2023.e1997537810027
     [Google Scholar]
  62. LvD. ZhongC. DixitD. YangK. WuQ. GoduguB. PragerB.C. ZhaoG. WangX. XieQ. BaoS. HeC. HeilandD.H. RosenfeldM.G. RichJ.N. EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma.Mol. Cell2023832343344351.e710.1016/j.molcel.2023.10.02537979586
     [Google Scholar]
  63. ShiZ. YuanH. CaoL. LinY. AKT1 participates in ferroptosis vulnerability by driving autophagic degradation of FTH1 in cisplatin-resistant ovarian cancer.Biochem. Cell Biol.2023101542243110.1139/bcb‑2022‑036137011414
     [Google Scholar]
  64. LiuY. GongS. LiK. WuG. ZhengX. ZhengJ. LuX. ZhangL. LiJ. SuZ. LiuY. XieJ. ChenJ. LiY. Coptisine protects against hyperuricemic nephropathy through alleviating inflammation, oxidative stress and mitochondrial apoptosis via PI3K/Akt signaling pathway.Biomed. Pharmacother.202215611394110.1016/j.biopha.2022.11394136411660
     [Google Scholar]
  65. GongR. RifaiA. DworkinL.D. Activation of PI3K–Akt–GSK3β pathway mediates hepatocyte growth factor inhibition of RANTES expression in renal tubular epithelial cells.Biochem. Biophys. Res. Commun.20053301273310.1016/j.bbrc.2005.02.12215781227
     [Google Scholar]
  66. LiY. WanC. LiF. XinG. WangT. ZhouQ. WenT. LiS. ChenX. HuangW. Indirubin attenuates sepsis by targeting the EGFR/SRC/PI3K and NF-κB/MAPK signaling pathways in macrophages.Front. Pharmacol.202516154206110.3389/fphar.2025.154206140144662
     [Google Scholar]
  67. ZhengX.J. ChenY. YaoL. LiX.L. SunD. LiY.Q. Identification of new hub- ferroptosis-related genes in Lupus Nephritis.Autoimmunity2024571231920410.1080/08916934.2024.231920438409788
     [Google Scholar]
  68. ZhaoW.M. WangZ.J. ShiR. ZhuY. LiX.L. WangD.G. Analysis of the potential biological mechanisms of diosmin against renal fibrosis based on network pharmacology and molecular docking approach.BMC Complement. Med. Ther.202323115710.1186/s12906‑023‑03976‑z37179298
     [Google Scholar]
  69. XuM. TrungT.S. ZhuZ. LiS. GongS. ChengN. ZhouP. WangS. ESR1-dependent suppression of LCN2 transcription reverses autophagy-linked ferroptosis and enhances sorafenib sensitivity in hepatocellular carcinoma.J. Physiol. Biochem.202581229931210.1007/s13105‑025‑01073‑y40126852
     [Google Scholar]
  70. XueQ. KangR. KlionskyD.J. TangD. LiuJ. ChenX. Copper metabolism in cell death and autophagy.Autophagy20231982175219510.1080/15548627.2023.220055437055935
     [Google Scholar]
  71. del BalzoU. SignoreP.E. WalkinshawG. SeeleyT.W. BrennerM.C. WangQ. GuoG. ArendM.P. FlippinL.A. ChowF.A. GervasiD.C. KjaergaardC.H. LangsetmoI. GuenzlerV. LiuD.Y. KlausS.J. LinA. NeffT.B. Nonclinical characterization of the hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat, a novel treatment of anemia of chronic kidney disease.J. Pharmacol. Exp. Ther.2020374234235310.1124/jpet.120.26518132487538
     [Google Scholar]
  72. ChangW.T. BowY.D. FuP.J. LiC.Y. WuC.Y. ChangY.H. TengY.N. LiR.N. LuM.C. LiuY.C. ChiuC.C. A marine terpenoid, heteronemin, induces both the apoptosis and ferroptosis of hepatocellular carcinoma cells and involves the ROS and MAPK pathways.Oxid. Med. Cell. Longev.202120211768904510.1155/2021/768904533488943
     [Google Scholar]
  73. YeQ. ZengC. LuoC. WuY. Ferrostatin-1 mitigates cognitive impairment of epileptic rats by inhibiting P38 MAPK activation.Epilepsy Behav2020103Pt A10667010.1016/j.yebeh.2019.10667031864943
     [Google Scholar]
  74. XuZ. ZhangM. WangW. ZhouS. YuM. QiuX. JiangS. WangX. TangC. LiS. WangC.H. ZhuR. PengW.X. ZhaoL. FuX. PatzakA. PerssonP.B. ZhaoL. MaoJ. ShuQ. LaiE.Y. ZhangG. Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosis.Toxicol. Appl. Pharmacol.202347311659510.1016/j.taap.2023.11659537328118
     [Google Scholar]
  75. YeY. ChenY. WuH. FuY. SunY. WangX. LiP. WuZ. WangJ. YangZ. ZhouE. Investigations into ferroptosis in methylmercury-induced acute kidney injury in mice.Environ. Toxicol.20233861372138310.1002/tox.2377036880449
     [Google Scholar]
  76. SuL. JiangX. YangC. ZhangJ. ChenB. LiY. YaoS. XieQ. GomezH. MuruganR. PengZ. Pannexin 1 mediates ferroptosis that contributes to renal ischemia/reperfusion injury.J. Biol. Chem.201929450193951940410.1074/jbc.RA119.01094931694915
     [Google Scholar]
  77. LiD. XieX. ZhanZ. LiN. YinN. YangS. LiuJ. WangJ. LiZ. YiB. ZhangH. ZhangW. HIF-1 induced tiRNA-Lys-CTT-003 is protective against cisplatin induced ferroptosis of renal tubular cells in mouse AKI model.Biochim. Biophys. Acta Mol. Basis Dis.20241870716727710.1016/j.bbadis.2024.16727738871033
     [Google Scholar]
  78. McGettrickA.F. O’NeillL.A.J. The role of HIF in immunity and inflammation.Cell Metab.202032452453610.1016/j.cmet.2020.08.00232853548
     [Google Scholar]
  79. DudowiczJ. FreedK.F. DouglasJ.F. Lattice cluster theory of associating polymers. II. Enthalpy and entropy of self-assembly and Flory-Huggins interaction parameter χ for solutions of telechelic molecules.J. Chem. Phys.2012136606490310.1063/1.368125622360220
     [Google Scholar]
  80. RainioO. TeuhoJ. KlénR. Evaluation metrics and statistical tests for machine learning.Sci. Rep.2024141608610.1038/s41598‑024‑56706‑x38480847
     [Google Scholar]
  81. ChenJ. QiuC. LiH. ZhengX. Role of molecular packing in solvent-mediated ellagic acid·phenazine co-crystals toward biological activity enhancement and rational drug design.Cryst. Growth Des.202424218829883710.1021/acs.cgd.4c00805
     [Google Scholar]
  82. ChenC. AiQ. ShiA. WangN. WangL. WeiY. Oleanolic acid and ursolic acid: Therapeutic potential in neurodegenerative diseases, neuropsychiatric diseases and other brain disorders.Nutr. Neurosci.202326541442810.1080/1028415X.2022.205195735311613
     [Google Scholar]
  83. CrespoI. García-MediavillaM.V. GutiérrezB. Sánchez-CamposS. TuñónM.J. González-GallegoJ. A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells – CORRIGENDUM.Br. J. Nutr.20231299165610.1017/S000711452200372536876716
     [Google Scholar]
  84. SpeiskyH. Arias-SantéM.F. FuentesJ. Oxidation of quercetin and kaempferol markedly amplifies their antioxidant, cytoprotective, and anti-inflammatory properties.Antioxidants202312115510.3390/antiox1201015536671017
     [Google Scholar]
  85. LinB. LiuL. LuY. ZhangD.W. Clinical study of Shenqi Dihuang Decoction and Xiaochengqi Decoction combined with hemodialysis in the treatment of the patients with CKD stage 5 and Qi and Yin deficiency and turbid poison inherent pattern.Int. J. Tradit. Chin. Med.202380781210.3760/cma.j.cn115398‑20210719‑00180
     [Google Scholar]
  86. JinZ. WangX. Traditional Chinese medicine and plant-derived natural products in regulating triglyceride metabolism: Mechanisms and therapeutic potential.Pharmacol. Res.202420810738710.1016/j.phrs.2024.10738739216839
     [Google Scholar]
  87. von Samson-HimmelstjernaF.A. KolbrinkB. RiebelingT. KunzendorfU. KrautwaldS. Progress and setbacks in translating a decade of ferroptosis research into clinical practice.Cells20221114213410.3390/cells1114213435883577
     [Google Scholar]
/content/journals/cmc/10.2174/0109298673409766250729110405
Loading
Mechanistic Insights into the Ferroptosis-Regulating Effects of EF in the Treatment of Chronic Renal Failure
Curr. Med. Chem. 33, 1284 (2026); https://doi.org/10.2174/0109298673409766250729110405
/content/journals/cmc/10.2174/0109298673409766250729110405
/content/journals/cmc/10.2174/0109298673409766250729110405
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): chronic renal failure; Eriobotryae folium; ferroptosis; molecular docking; molecular dynamics; SRC

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test